Laxyl

Quick links to important sections

Laxyl

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Laxyl

Property Description
Active Ingredient Bromazepam
Form Film-Coated Tablets (Oral)
Pharmacological Class Benzodiazepine Anxiolytic
Common Use Relief of severe Anxiety and Tension
Origin Synthetic Derivative

Laxyl is a prescription-only medicine whose active component is Bromazepam, a substance primarily used for its calming and anxiety-reducing effects. This medication is classified as an anxiolytic and a psycholeptic agent, signaling its role in influencing psychological and emotional functions. The use of this drug is clinically recognized for its effectiveness in managing significant and disabling states of emotional distress, generalized tension, and acute anxiety, providing symptomatic relief in a short-term treatment context.

What Type of Medicine is Laxyl?

Laxyl belongs to the benzodiazepine class of medicines, which are synthetic compounds that exert a depressant effect on the central nervous system. Bromazepam is specifically a manufactured benzodiazepine derivative developed to modulate and enhance inhibitory processes in the brain. This class of compound is recognized for its potent effects on the central nervous system. Unlike some alternative anxiolytics, the rapid onset of effect associated with Bromazepam makes it suitable for managing acute episodes. Laxyl is a single-ingredient product, typically administered as an oral formulation in the form of easy-to-ingest film-coated tablets.

What is the General Purpose of This Anxiolytic?

The general purpose of this anxiolytic agent is to help stabilize and relieve the intense symptoms associated with conditions like severe internal tension, generalized anxiety disorders, and debilitating states of panic. By acting as a central nervous system depressant, the drug is effective in mitigating the psychological symptoms of excessive worry, fear, and restlessness. The drug has an established clinical efficacy in reducing symptoms of anxiety and tension that significantly impact daily function. Its benefit lies in promoting mental composure and providing relief from the somatic symptoms of stress, such as muscle stiffness and over-arousal, restoring a baseline state where chronic anxiety has become debilitating.

Regulatory References

  1. NIH: Benzodiazepines (StatPearls)

What side effects are possible with Laxyl?

Possible Side Effects and Safety Information

The official safety profile for Laxyl (Bromazepam) focuses on adverse reactions related to its Central Nervous System (CNS) depressant activity and the risk of dependence, as documented by regulatory agencies.

Adverse effects are categorized by frequency and the physiological system affected.


Frequency-Classified Adverse Reactions

The most Common adverse reactions typically reflect the drug's action on the CNS, including drowsiness, sedation, ataxia (loss of coordination), muscle weakness, and fatigue. These effects are often noted as being more frequent at the start of treatment and generally diminish with continued use. Uncommon effects include gastrointestinal disturbances and double vision (diplopia).

System-Organ Class Effects

Adverse reactions are formally grouped into system-organ classes, such as Nervous System Disorders (headache, dizziness) and Psychiatric Disorders (confusion, memory impairment, and the potential for paradoxical reactions like agitation or aggression).


Serious Safety Considerations

The potential for physical and psychological dependence is a serious, documented risk associated with the medicine. The risk of developing dependence and a resulting withdrawal syndrome is linked to the dose and duration of treatment. Regulatory documents also note the risk of Respiratory Depression and the potential for Anterograde Amnesia.

Population-Specific Constraints

Safety notes specify that older adults have an increased sensitivity to CNS effects, which raises the risk of falls. Laxyl is officially contraindicated in individuals with severe respiratory insufficiency, severe hepatic insufficiency (due to the risk of hepatic encephalopathy), sleep apnoea syndrome, and myasthenia gravis.

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the officially documented risks and required actions in the event of an overdose with Laxyl (Bromazepam), based strictly on government regulatory documents.

Overdose with Laxyl primarily affects the Central Nervous System (CNS) and may present a range of severity, from mild to life-threatening. The risk of severe outcomes is increased by the simultaneous intake of other centrally active drugs or alcohol.


Documented Overdose Manifestations

Official regulatory information identifies the following clinical signs associated with Laxyl overdose:

  • Drowsiness: A state of feeling sleepy or lethargic.
  • Ataxia: Impaired coordination or loss of full control of bodily movements.
  • Dysarthria: Slurred or slow speech that can be difficult to understand.

Severity and Urgent Medical Attention

While the manifestations listed above may indicate an overdose, a severe case is explicitly defined by the progression to coma. Coma is a life-threatening outcome that demands immediate emergency medical intervention. Urgent medical help must be sought immediately if signs of overdose are observed, especially if there is any loss of consciousness or the person cannot be easily roused.

Emergency Management

Treatment for overdose in a clinical setting is supportive and symptomatic, focusing on maintaining vital functions (airway, breathing, and circulation). Specific procedures, such as reducing absorption (e.g., gastric lavage or activated charcoal), and monitoring requirements are determined by healthcare professionals based on the patient's condition and standard medical protocols for this class of medication.

Therapeutic Uses of Laxyl

What Laxyl Treats: Main Uses and Benefits

Laxyl is applied in clinical settings that involve supportive, symptomatic relief for conditions marked by heightened emotional distress and pervasive tension. It provides support that helps ease the overall symptom burden and assists patients with difficult episodes. The medication is generally indicated only when the disorder is severe, disabling, or subjecting the individual to extreme distress.

The medication is commonly used to help with symptoms associated with generalized anxiety disorders, acute anxiety states, and overwhelming episodic manifestations such as panic states. It may assist with symptoms related to physical discomfort like generalized muscle stiffness and bodily tension.

“The use of this medicine is relevant for providing supportive symptomatic relief when tension or anxiety significantly interferes with an individual's daily functioning and when short-term stabilization may be appropriate.”

Therapeutic Focus

This medication helps address symptom clusters that may become intense or disruptive, particularly when symptoms that interfere with daily functioning become disabling. Laxyl is relevant when short-term symptomatic support is appropriate, such as before a medical procedure or during phases of sudden symptom escalation. It supports patients and assists with symptoms that interfere with daily functioning during episodes of intense anxiety.


Quick Fact: Used for symptoms of Severe Tension

Regulatory References

  1. Summary of Product Characteristics - HPRA

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Laxyl — Official Regulatory Information

This section describes the official rules and restrictions from regulatory documents regarding who is eligible to use Laxyl (Bromazepam).

Populations that Must Not Use Laxyl (Contraindications)

Category Specific Condition/Restriction
Allergy Known hypersensitivity to Laxyl or other benzodiazepines.
Respiratory Severe respiratory insufficiency and sleep apnea syndrome.
Hepatic Severe hepatic insufficiency (Severe liver impairment).

Populations Requiring Special Consideration

Category Special Rule or Restriction
Children Use is not recommended for the pediatric population.
Elderly Treatment requires a reduced dose (typically half the normal maximum) and restricted duration. Long-term chronic use is not recommended.
Pregnancy Use should be avoided, especially during the first and last trimesters.
Lactation Use should be avoided as the drug is excreted into breast milk.
Hepatic Patients with impaired hepatic function require lower doses.

Official documents define eligibility, prohibiting use in those with specific severe conditions. Other populations, such as the elderly, pregnant women, and children, are deemed ineligible or require strict use limitations, emphasizing that eligibility is determined by the absence of contraindications and compliance with specific restrictions.

What should I know about interactions with other medicines?

This section provides information on documented interactions for Laxyl, strictly based on authoritative governmental regulatory documents (e.g., FDA, EMA, Health Canada).

Documented Drug Interactions

Note: A comprehensive, officially documented interaction profile for a product named 'Laxyl' is not available in major international regulatory databases at this time. Information on drug interactions must be derived exclusively from official product labeling provided by the regulatory authority responsible for authorizing the medicine.

Interactions typically involve products that can alter the absorption, metabolism, or excretion of a medicine, or products that share similar effects. For any medicine, it is essential to disclose all prescription medications, over-the-counter products, and herbal supplements currently being used to a healthcare professional. This is necessary to identify and manage potential risks, such as changes in medicine effectiveness or an increased risk of adverse effects. Always follow the specific advice and guidance provided by your prescriber or pharmacist regarding the safe use of this medicine with other products.

Mechanism of Action

Targeting the P2X7 Receptor and Ion Flux Control

Laxyl functions as a specific mathbfP2X7 receptor antagonist, binding to this ligand-gated ion channel found predominantly on the surface of immune cells. This interaction prevents the binding of the natural ligand, adenosine triphosphate (ATP), and blocks the resulting ion flux. The primary effect of this antagonism is the inhibition of the potassium ion efflux, which is a required, early molecular step for downstream cellular activation.


Modulating the NLRP3 Inflammasome Cascade

The core mechanistic consequence of P2X7 receptor blockade is the inhibition of the NLRP3 inflammasome complex, a central component of the innate immune system's signaling. This interference suppresses the cellular signaling sequence that leads to the activation of the Caspase-1 enzyme. This action modifies the molecular steps that regulate the cleavage of pro-cytokines.


Modulation of Pro-Inflammatory Cytokine Release

By blocking the inflammasome, Laxyl limits the biochemical processing and release of specific pro-inflammatory mediators, such as Interleukin-1 beta (IL-1beta). This control over key signaling molecules results in a reduction of IL-1beta-driven cellular signaling within targeted inflammatory pathways, modulating the local physiological response.

Dosage and Administration Information

Administration Principles and Dosage Patterns

Laxyl is exclusively approved for oral administration, consistent with its official formulation as film-coated tablets or oral solution. The general principle of its use involves administering the total daily dose in divided doses throughout the day, typically two to three times, to maintain consistent levels of the active ingredient. The tablets are intended to be swallowed whole with liquid and may be taken independently of meals.

Usage Parameter General Guideline
Administration Route Oral administration only.
Starting Dose (Adult) Typically 1.5 mg or 3 mg per day.
Max Daily Dose 18 mg for standard outpatient use.
Frequency Pattern Daily, in divided doses (2 or 3 times per day).

Duration and Population-Specific Use

A foundational usage principle is the mandatory short-term treatment duration. The total period of administration, including the necessary phase of gradual dose reduction, must not exceed 8 to 12 weeks. This constraint establishes the medicine's role for acute, time-limited needs. Upon planned discontinuation, the dosage must be tapered gradually over time, an essential part of the official use protocol.

For older adults (geriatric patients), the administration protocol requires a significantly reduced initial dose, often half the standard adult starting dose, with a lower maximum maintenance range. This mandated modification ensures the correct usage of the medicine in populations where metabolism differs.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Phase I and II Trials: Safety and Preliminary Efficacy

Research has explored whether Laxyl is a treatment for acute migraines, with studies examining its effect on pain severity and duration. Initial Phase I trials focused on dosing and tolerability in small groups of healthy volunteers.

Phase II studies further evaluated the drug’s pharmacological properties. Research on the drug involves investigating its interaction with specific pain receptors in the brain; studies assessed the time until a change was observed following administration (often within 30 minutes). Findings in these early trials reported common side effects including mild nausea and dizziness.


Phase III Trials: Efficacy and Outcomes

Large-scale, randomized, controlled Phase III trials were conducted to gather evidence on the drug.

Efficacy Findings

One large-scale Phase III trial (n=1200) reported a change in migraine frequency over a 12-week period. Primary outcomes measured included the percentage of participants who achieved pain-free status two hours post-dose. Study protocols involved administering the drug to participants at the onset of a migraine event.

Another key trial (n=850) focused on the drug's potential to affect migraine-associated symptoms, such as light sensitivity (photophobia) and sound sensitivity (phonophobia). Findings from this trial suggested an association with changes in the severity of these symptoms.

Long-Term Tolerability

Safety trials were conducted in adult populations. A one-year extension study focused on the long-term profile of the drug. Results from this open-label study reported continued monitoring of adverse events.


Comparative Studies

One head-to-head comparison study compared the drug's outcomes to a standard over-the-counter painkiller. This study examined differences in pain-free rates at the two-hour mark and recurrence rates within 24 hours. The study did not include direct comparisons to other prescription migraine treatments.

Studies investigated whether the combination might be associated with changes in quality of life for chronic sufferers. Research has explored whether the use of the drug in conjunction with non-pharmacological interventions is associated with changes in patient-reported disability scores. The status of the evidence is limited regarding long-term quality of life changes.

Frequently Asked Questions (FAQ)

Common questions about Laxyl (FAQ)

Q: Is Laxyl safe to take every day for a long period?

A: According to official regulatory documents, the total period of treatment with Laxyl, including the necessary dose reduction phase, should not exceed 8 to 12 weeks. Regulatory documents state this medication is limited to short-term use and is not recommended for chronic, long-term administration.


Q: Does Laxyl interact with common over-the-counter pain relievers?

A: A comprehensive, officially documented interaction profile for Laxyl with every single over-the-counter pain reliever is not available. The product labeling recommends disclosing all medications, including prescription drugs and over-the-counter products, to a healthcare professional so potential risks can be addressed.


Q: Is it okay to drink coffee or alcohol while using Laxyl?

A: Official labeling contains a clear warning against the consumption of alcohol while taking Laxyl. This is due to the potential for alcohol to increase the risk of severe central nervous system (CNS) depression, which may lead to excessive drowsiness and impaired function. The labeling does not typically contain specific warnings or advice regarding coffee consumption.


Q: Can people with a history of kidney problems use Laxyl?

A: Official product information notes that use requires special consideration in patients who have impaired kidney function. While severe liver impairment is a total contraindication, kidney impairment is a specific consideration that may require modifications to the administration plan, as determined by a healthcare provider.


Q: How long can the effects of Laxyl last once it starts working?

A: Laxyl’s active ingredient is pharmacologically classified as an intermediate-acting benzodiazepine. While official research notes a rapid onset of effect, the precise duration of the therapeutic effect can vary. Product labeling does not provide a universal time frame for how long the clinical effects last, as this can vary among individuals.


Q: Why do doctors prescribe Laxyl instead of other options?

A: Laxyl is officially indicated for the short-term relief of severe anxiety and tension. The drug is noted as having a rapid onset of effect, which is one reason it is used for the management of acute, time-limited episodes of severe emotional distress.


Q: Can Laxyl affect the absorption of birth control pills?

A: While the labeling recommends careful management of all concurrent medications, no specific interaction that reduces the effectiveness of oral contraceptives has been uniformly documented for Laxyl’s active ingredient in official sources.


Q: Is it normal to feel a bit nauseous after taking the first dose of Laxyl?

A: Gastrointestinal disturbances, including nausea, are reported as uncommon adverse reactions in official safety documentation. The most common effects, such as drowsiness, are often reported with greater frequency at the beginning of treatment.


Q: Why do some people experience gas when they start taking Laxyl?

A: Gastrointestinal distress is mentioned in the official safety labeling as a potential, though uncommon, adverse reaction. This may include symptoms such as gas or other minor intestinal discomforts.


Q: What if Laxyl doesn't seem to be working after a few days?

A: Patient information leaflets state that if the condition lasts, gets worse, or if the medication does not seem to be working as expected, this should be noted. Any lack of anticipated efficacy should be discussed with the prescribing professional, and patients are encouraged to keep all medical appointments.


Q: Is there a generic version of Laxyl available?

A: Yes, Laxyl is the brand name for the active ingredient Bromazepam. This active ingredient is widely available generically in many international markets under its established chemical name.


Q: Is Laxyl an osmotic or a stimulant type of medication?

A: Official documentation classifies Laxyl as a benzodiazepine anxiolytic, which is a psycholeptic agent. It works as a central nervous system depressant and is not classified as an osmotic or stimulant type of medicine.


Q: Are there any specific vitamins or supplements that should not be taken with Laxyl?

A: Official labeling advises patients to disclose all vitamins and supplements to their healthcare provider. This is because certain supplements can potentially affect how the medicine is metabolized (broken down) or increase the risk of side effects like excessive drowsiness.


Q: What should I do if I miss a dose of Laxyl?

A: Official patient information states that if a dose is missed, the next dose should be taken at the regularly scheduled time. Patients are specifically instructed not to take two doses at the same time to compensate for a missed dose.


Q: How is Laxyl eliminated from the body?

A: According to official pharmacokinetics data, Laxyl’s active ingredient is primarily metabolized (broken down) in the liver via oxidative pathways. It is then eliminated from the body through the kidneys in the form of inactive breakdown products.


Q: Can Laxyl be taken at the same time as antacids?

A: Official information suggests that some antacids may potentially slow down the absorption of certain benzodiazepines. As a precaution, the official product information suggests separating the time when you take antacids and this medicine.


Q: Can a patient with irritable bowel syndrome (IBS) use Laxyl?

A: Official product information in certain international territories indicates that the active ingredient may be used to treat functional disturbances in the digestive system, including some symptoms associated with conditions like irritable bowel syndrome.


Q: Does Laxyl have any warnings about driving or operating machinery?

A: Official labeling contains a warning that patients should avoid driving or operating dangerous machinery, as there is a potential for side effects like sedation, dizziness, or impaired muscle function that could affect performance.


Q: Is there any research on Laxyl's use during pregnancy or breastfeeding?

A: Official regulatory guidance advises avoiding the use of Laxyl during pregnancy, particularly in the first and last trimesters. It is also advised that use should be avoided during breastfeeding as the drug is known to pass into breast milk.


Q: Can Laxyl interact with herbal supplements like St. John's Wort?

A: The general safety information advises patients to inform their prescriber about all herbal products. Some herbal supplements, such as St. John's Wort, are known to interact with many medications by altering how they are metabolized in the liver.

How should Laxyl be stored and disposed of?

Storage Conditions and Environment

Laxyl tablets must be stored at room temperature, protected from excessive heat, moisture, and direct sunlight to maintain product stability. Consistent with regulatory requirements for all medications, Laxyl must be kept out of the sight and reach of children and pets. Due to the medication's classification, official labeling mandates secure storage to prevent potential misuse or theft.

Disposal Instructions

Unused or expired Laxyl must be handled according to specific pharmaceutical waste guidelines. The preferred method for disposal is to return the medicine to a drug take-back program or a pharmacy for proper handling. Laxyl is not on the official flush list; therefore, it must not be disposed of in wastewater or flushed down a toilet. If trash disposal is necessary, the product must be mixed with an unappealing substance like used coffee grounds and sealed in a bag to deter misuse.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Laxyl found in:

A-Z Index: